Argentum 47 Inc. announced that it has entered into talks with a European medical cannabis company that is fully integrated with strategic assets along the entire value chain including cultivation, processing, and distribution of dry flower and oil derivatives. With the global medical cannabis market valued at USD 11.0 billion in 2021 and projected to reach USD 54.34 billion by 2029, (source: Data Bridge Market Research, July 2022), Argentum is striving to capitalize on the European cannabis industry, which is expected to grow significantly in the coming years as more countries legalize medicinal marijuana and its related products.